dihexa predicted pka Development of a predictor (pKaLearn) by leveraging teaching experience to improve machine learning Dihexa (PNB-0408)

Cagrilintide is a long-acting amylin analog that promotes fullness and slows digestion, while Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways at once

At the 5mg/ml concentration, the same one-unit difference is only 0.05mg, a 2% error

To avoid this, the peptide should be dissolved in sterile distilled water, or filtered with a 0.45 or 0.2 m pore size filter for sterilization

Gastrointestinal Support GI side effects are the most common reason patients discontinue GLP-1 therapy

They start with a 5mg vial for Phase 1 and Phase 2, then transition to 10mg vials once they reach Phase 3

Tell all your healthcare providers you are taking tirzepatide before any planned surgery or procedure